PMA device
TOUCH® CMC 1 Prosthesis
Keri Medical SA · Prosthesis, Finger, Semi-Constrained, Metal/Polymer (SFA, Class III) · First FDA decision Jul 10, 2025, newest May 12, 2026Hand and wrist conditions
Last checked: Nov 20, 2026Source: FDA, CMS, ClinicalTrials.gov, PubMed
FDA decisions
5
PMA pathway
Device trials
5
Naming "TOUCH CMC 1"
MAUDE reports
0
Brand "TOUCH CMC 1", since 2015
PubMed studies
0
Mentioning "TOUCH CMC 1"
AI summary across all sources
Written by AI from the FDA, CMS, ClinicalTrials.gov, MAUDE and PubMed data on this page, plus web searches for payment facts.
Product review deck
A slide deck reviewing TOUCH® CMC 1 Prosthesis
About ten slides on the technology, clinical evidence, regulatory history and commercialization, built with AI from the data on this page and web research, with sources. Download it as PowerPoint to edit or as PDF to share.
- Executive summary and key facts
- Technology
- Clinical evidence and trials
- Regulatory history and safety
- Reimbursement, market and competition
- Risks, outlook and sources
AI-written from public data and may contain mistakes. Check each fact against its source before relying on it. Not investment, legal, reimbursement or medical advice.
FDA decisions
The newest 0 of 5 decisions filed under this name.
FDA's records could not be loaded.
Medicare coverage
National and local coverage documents whose titles match this device or its device type. Payment add-ons (NTAP, pass-through, TCET) and likely codes are covered in the summary above.
No Medicare coverage document has a title matching this device or device type. Many devices are paid under existing codes without one.
Clinical trials
Device studies on ClinicalTrials.gov that name "TOUCH CMC 1", any status and sponsor, newest update first.
Uppsala UniversityAcademic, hospital or other
NCT07569549 · 84 participants (planned) · Start Sep 4, 2026 · Primary completion May 2030
Device: Implantation of trapeziometacarpal prosthesis · For: Thumb Osteoarthritis; Thumb Carpometacarpal Joint Osteoarthritis; Carpometacarpal (CMC) Joint Arthritis and 1 more
Sites: Uppsala, Sweden
- TOUCH® CMC 1 New Enrollment US StudyRecruiting
Keri Medical SANot on our public-company list
NCT07405983 · 163 participants (planned) · Start Mar 4, 2026 · Primary completion Nov 2029
Device: TOUCH® CMC 1 Prosthesis · For: Osteoarthritis Thumb; Thumb Carpometacarpal Joint Osteoarthritis
Sites: Aurora, Colorado; Indianapolis, Indiana; Morrisville, North Carolina · 4 sites in all
- Post Market Clinical Follow-Up TOUCH® CMC 1Active, not recruiting
Keri Medical SANot on our public-company list
NCT06546306 · 216 participants · Start Nov 22, 2019 · Primary completion Feb 22, 2022
Device: TOUCH® CMC 1 · For: Osteoarthritis Thumb
Sites: Aix-en-Provence, France; Beaumont, France; Bezannes, France · 6 sites in all
2 more trials with a free account
Adverse event reports (MAUDE)
Reports received since 2015 naming the brand "TOUCH CMC 1", and for the whole product code for context.
This brand
0 reports: 0 malfunction, 0 injury, 0 death
Whole product code SFA
0 reports: 0 malfunction, 0 injury, 0 death
Newest reports for this brand
No MAUDE reports name this brand.
Recalls
From FDA's recall database. FDA lists each recalled product separately, so one recall can appear several times. A recall is often a correction or a labeling change, not a removal from the market.
No recall in FDA's data is linked to these FDA numbers.
Published research
The most relevant PubMed records for "TOUCH CMC 1"[tiab]. The summary above synthesizes these.
No PubMed record mentions this device by name.
For information only. Nothing on this page is investment, legal, tax or medical advice, and nothing here is an offer to sell or a solicitation of an offer to buy any security. The data comes from public government sources, which can be incomplete, delayed or wrong. Check the original record before relying on it.